What is the Wanbury PE ratio today?
Wanbury's PE ratio is 11.4 at the 29 October 2026 close (₹181.93 a share): a market capitalisation of ₹636 crore divided by standalone net profit of ₹55.9 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹66.1 crore) it is 9.6.
What is the Wanbury net worth?
Wanbury's net worth — shareholders' equity in its standalone balance sheet — was ₹144 crore on 31 March 2026, up 143.7% from ₹59.3 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹636 crore at the 29 October 2026 close.
What is the Wanbury book value per share?
Wanbury's book value per share was ₹41.34 on 31 March 2026: shareholders' equity of ₹144 crore divided by the 3.49 crore shares in issue, up 128.6% from ₹18.09 a year earlier. The share price at the 29 October 2026 close was ₹181.93.
What is the Wanbury PB ratio (price to book value)?
Wanbury's price-to-book (PB) ratio is 4.40 at the 29 October 2026 close: a market capitalisation of ₹636 crore divided by shareholders' equity (book value) of ₹144 crore on 31 March 2026. That is a book value of ₹41.34 per share against a share price of ₹181.93.
What is the Wanbury ROE and ROCE?
In FY26, Wanbury's return on equity (ROE) was 64.9% and its return on capital employed (ROCE) was 33.3%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 70.0% and ROCE 34.2%.
What is the Wanbury promoter holding?
Promoters held 42.98% of Wanbury on 30 September 2026, down 0.04 percentage points from 43.02% the previous quarter and down 0.11 percentage points from 43.09% a year earlier, according to the shareholding pattern filed with NSE.
What is the Wanbury market cap?
Wanbury's market capitalisation was ₹636 crore at the 29 October 2026 close: 3.49 crore shares at ₹181.93 each.
What is the Wanbury debt to equity ratio?
Wanbury's debt-to-equity ratio was 1.49 on 31 March 2026: borrowings of ₹215 crore against total equity of ₹144 crore. A year earlier, on 31 March 2025, it was 2.92.
What is the Wanbury EPS?
Wanbury's basic earnings per share (EPS) were ₹20.55 in FY26, against ₹9.32 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹17.36.
Is Wanbury debt free?
No. Wanbury had borrowings of ₹215 crore on 31 March 2026 (standalone balance sheet), a debt-to-equity ratio of 1.49. Its cash and current investments were ₹7.6 crore, so its net debt was ₹208 crore.
What is the Wanbury free cash flow?
In FY26, Wanbury generated ₹31.5 crore of cash from operations and spent ₹59.1 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹27.5 crore. In FY25 it was −₹22.9 crore.
What are the Wanbury latest quarterly results?
Wanbury's latest results are for Q1 FY27 (April–June 2026), filed on 11 August 2026: standalone net profit ₹3.2 crore, down 76.0% from ₹13.5 crore in Q1 FY26; revenue from operations ₹166 crore, up 1.5% year on year.
What is the Wanbury shareholding pattern?
On 30 September 2026, Wanbury's shares were held by promoters 42.98%, foreign portfolio investors (FII/FPI) 0.71%, domestic institutions (DII) 0.02% (including mutual funds at 0.00%) and retail and other non-institutional investors 56.28%. Over the year, FII holding was down 0.11 percentage points from 0.82% and DII holding was up 0.02 percentage points from 0.00%.
How does Wanbury compare with its peers?
On FY26 standalone figures, against Anlon Healthcare, Anuh Pharma and Bajaj Healthcare: Wanbury's operating margin of 14.2% is the second highest of the four (Anlon Healthcare 25.4%, Anuh Pharma 6.5%, Bajaj Healthcare 12.7%; peer average 14.8%); its return on equity of 64.9% is the highest of the four (Anlon Healthcare 13.3%, Anuh Pharma 12.1%, Bajaj Healthcare 3.2%; peer average 9.5%).
How does the Wanbury PE ratio compare with its peers?
At the 29 October 2026 closing prices, on FY26 net profit, Wanbury's PE ratio is 9.6, the lowest of the four: Anlon Healthcare 48.0, Anuh Pharma 19.5 and Bajaj Healthcare 66.8, a peer average of 44.8. Each is the company's market capitalisation at that price divided by its FY26 net profit.
What is the Wanbury revenue and profit in FY26?
In FY26 (April 2025–March 2026), Wanbury's standalone net profit was ₹66.1 crore, up 116.6% from ₹30.5 crore in FY25, on revenue from operations of ₹650 crore (up 8.5%).
When are the Wanbury next results?
Wanbury will announce its Q2 FY27 results (July–September 2026) on Wednesday, 4 November 2026, the date of the board meeting it has notified to the exchanges.
Wanbury vs Anlon Healthcare: how do they compare?
In FY26, Wanbury earned net profit of ₹66.1 crore on revenue of ₹650 crore, against ₹27.8 crore on ₹176 crore for Anlon Healthcare. Wanbury's operating margin was 14.2% (Anlon Healthcare 25.4%) and its return on equity 64.9% (Anlon Healthcare 13.3%). At the 29 October 2026 close, Wanbury's market capitalisation was ₹636 crore against ₹1,335 crore for Anlon Healthcare, and its PE ratio on FY26 profit 9.6 against 48.0.
Standalone figures from the company's filings with NSE; prices are NSE closing prices.
